I 

109TH CONGRESS 

1ST SESSION H. R. 2565 

To reauthorize the Office of National Drug Control Policy Act and to establish 

minimum drug testing standards for major professional sports leagues. 

IN THE HOUSE OF REPRESENTATIVES 

MAY 24, 2005 

Mr. TOM DAVIS of Virginia (for himself, Mr. WAXMAN, Mr. SOUDER, Mr. 

CUMMINGS, Mr. SHAYS, Mr. OWENS, Mr. MCHUGH, Mrs. MALONEY, Mr. 

PLATTS, Mr. DAVIS of Illinois, Mr. DUNCAN, Mr. CLAY, Mr. ISSA, Mr. 

LYNCH, Mr. DENT, Ms. LINDA T. SA ́NCHEZ of California, Ms. FOXX, and 

Ms. NORTON) introduced the following bill; which was referred to the 

Committee on Government Reform, and in addition to the Committees on 

Energy and Commerce and Education and the Workforce, for a period 

to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee 

concerned 

A BILL 

To reauthorize the Office of National Drug Control Policy 

Act and to establish minimum drug testing standards 

for major professional sports leagues. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. TABLE OF CONTENTS. 

4 The table of contents for this Act is as follows: 

Sec. 1. Table of contents. 
2 

•HR 2565 IH 

TITLE I—REAUTHORIZATION OF OFFICE OF NATIONAL DRUG 

CONTROL POLICY ACT 

Sec. 101. Short title. 

Sec. 102. Repeal of termination provision. 

Sec. 103. Authorization of appropriations. 

TITLE II—CLEAN SPORTS ACT OF 2005 

Sec. 201. Addition of minimum drug testing standards to Office of National 

Drug Control Policy Act. 

1 TITLE I—REAUTHORIZATION OF 

2 OFFICE OF NATIONAL DRUG 

3 CONTROL POLICY ACT 

4 SEC. 101. SHORT TITLE. 

5 This title may be cited as the ‘‘Office of National 

6 Drug Control Reauthorization Act’’. 

7 SEC. 102. REPEAL OF TERMINATION PROVISION. 

8 Section 715 of the Office of National Drug Control 

9 Policy Reauthorization Act of 1998 (Public Law 105–277; 

10 21 U.S.C. 1712) is repealed, and the law shall read as 

11 if such section was never in effect. 

12 SEC. 103. AUTHORIZATION OF APPROPRIATIONS. 

13 Section 714 of such Act (21 U.S.C. 1711) is amend14 ed— 

15 (1) by striking ‘‘title,’’ and inserting ‘‘subtitle, 

16 except activities for which amounts are otherwise 

17 specifically authorized by this subtitle,’’; and 

18 (2) by striking ‘‘1999 through 2003’’ and in19 serting ‘‘2006 through 2010’’. 
3 

•HR 2565 IH 

1 TITLE II—CLEAN SPORTS ACT 

2 OF 2005 

3 SEC. 201. ADDITION OF MINIMUM DRUG TESTING STAND4 ARDS TO OFFICE OF NATIONAL DRUG CON5 TROL POLICY ACT. 

6 (a) AMENDMENT.—The Office of National Drug Con7 trol Policy Act of 1998 (Public Law 105–277; 21 U.S.C. 

8 1701 et seq.) is amended— 

9 (1) by inserting before section 701 the fol10 lowing: 

11 ‘‘Subtitle A—Office of National 

12 Drug Control Policy’’; and 

13 (2) by adding at the end the following new sub14 title: 

15 ‘‘Subtitle B—Clean Sports Act of 

16 2005 

17 ‘‘SEC. 721. SHORT TITLE. 

18 ‘‘This subtitle may be cited as the ‘Clean Sports Act 

19 of 2005’. 

20 ‘‘SEC. 722. FINDINGS AND PURPOSE. 

21 ‘‘(a) FINDINGS.—Congress finds the following: 

22 ‘‘(1) The use of anabolic steroids and other per23 formance-enhancing substances by minors is a public 

24 health problem of national significance. 
4 

•HR 2565 IH 

1 ‘‘(2) Experts estimate that over 500,000 teen2 agers have used performance-enhancing substances, 

3 which medical experts warn can cause a litany of 

4 health problems for individuals who take them, in 

5 particular children and teenagers. 

6 ‘‘(3) The adverse health effects caused by 

7 steroids and other performance-enhancing sub8 stances include stunted growth, scarring acne, hair 

9 loss, dramatic mood swings, hormonal and metabolic 

10 imbalances, liver damage, a higher risk of heart dis11 ease and stroke later in life, as well as an increased 

12 propensity to demonstrate aggressive behavior, com13 mit suicide, and commit crimes. 

14 ‘‘(4) Professional athletes are role models for 

15 young athletes and influence the behavior of children 

16 and teenagers. 

17 ‘‘(5) Congressional testimony by parents of mi18 nors who used performance enhancing drugs, as well 

19 as medical and health experts, indicates that the ac20 tual or alleged use of performance-enhancing sub21 stances by professional athletes results in the in22 creased use of these substances by children and 

23 teenagers. 

24 ‘‘(6) Surveys and studies suggest a connection 

25 between the actual or alleged use of performance-en-
5 

•HR 2565 IH 

1 hancing substances by college and professional ath2 letes and the increased use of these substances by 

3 children and teenagers. 

4 ‘‘(7) The real or perceived tolerance of the use 

5 of performance-enhancing substances by professional 

6 athletes has resulted in both increased pressure on 

7 children and teenagers to use performance-enhanc8 ing drugs in order to advance their athletic careers 

9 and to professional sports loss of integrity. 

10 ‘‘(8) The adoption by professional sports 

11 leagues of strong policies to eliminate the use of per12 formance-enhancing substances would result in the 

13 reduced use of these substances by children and 

14 teenagers. 

15 ‘‘(9) Minimum drug testing standards for pro16 fessional sports established by Federal law would en17 sure the adoption of strong policies to eliminate the 

18 use of performance-enhancing substances in profes19 sional sports. 

20 ‘‘(10) Minimum drug testing standards for pro21 fessional sports established by Federal law would 

22 help return integrity to professional sports. 

23 ‘‘(11) Congress has for several years expressed 

24 a strong interest in the problem of the role of per-
6 

•HR 2565 IH 

1 formance-enhancing drugs in professional sports and 

2 other levels of sports. 

3 ‘‘(12) Congress has for several years regulated 

4 the use of anabolic steroids and other performance5 enhancing substances. 

6 ‘‘(13) Recent Federal laws regulating the use of 

7 anabolic steroids and other performance-enhancing 

8 substances were enacted in large part to reduce the 

9 prevalence of these substances in sports. 

10 ‘‘(14) Congress has for several years regulated 

11 both professional and amateur sports. 

12 ‘‘(b) PURPOSE.—The purpose of this subtitle is to 

13 protect the integrity of professional sports and the health 

14 and safety of athletes generally by establishing minimum 

15 standards for the testing of steroids and other perform16 ance-enhancing substances by professional sports leagues. 

17 ‘‘SEC. 723. DEFINITIONS. 

18 ‘‘In this subtitle: 

19 ‘‘(1) ANTI-DOPING CODE.—The term ‘anti20 doping code’ means the doping control standards es21 tablished in the United States Anti-Doping Agency 

22 Protocol for Olympic Movement Testing (excluding 

23 substances or methods prohibited in a particular 

24 sport, as defined in such protocol). 
7 

•HR 2565 IH 

1 ‘‘(2) COMMISSION.—The term ‘Commission’ 

2 means the Federal Trade Commission. 

3 ‘‘(3) DIRECTOR.—The term ‘Director’ means 

4 the Director of the Office of National Drug Control 

5 Policy. 

6 ‘‘(4) MAJOR PROFESSIONAL LEAGUE.—The 

7 term ‘major professional league’ means Major 

8 League Baseball, the National Basketball Associa9 tion, the National Football League, and the National 

10 Hockey League or any successor organization to 

11 those leagues. 

12 ‘‘(5) OFF-SEASON.—The term ‘off-season’ 

13 means the period of time in each calendar year out14 side of the season of play for each major profes15 sional league. 

16 ‘‘(6) PROFESSIONAL ATHLETE.—The term ‘pro17 fessional athlete’ means an individual who competes 

18 in a major professional league. 

19 ‘‘(7) PROFESSIONAL GAME.—The term ‘profes20 sional game’ means any game held in the United 

21 States between any professional teams of a major 

22 professional league. 

23 ‘‘(8) PROHIBITED METHOD OR SUBSTANCE.— 
8 

•HR 2565 IH 

1 ‘‘(A) PROHIBITED METHOD.—The term 

2 ‘prohibited method’ means a method listed and 

3 described in the Anti-Doping Code. 

4 ‘‘(B) PROHIBITED SUBSTANCE.—The term 

5 ‘prohibited substance’ means a substance listed 

6 and described in the Anti-Doping Code. 

7 ‘‘(C) PERIOD OF PROHIBITION.—A sub8 stance prohibited in-competition by the Anti9 Doping Code shall be a prohibited substance 

10 only during the season of play. Only a sub11 stance or method prohibited out-of-competition 

12 by the Anti-Doping Code shall be a prohibited 

13 substance or method during the off-season. 

14 ‘‘(9) SEASON OF PLAY.— 

15 ‘‘(A) IN GENERAL.—The term ‘season of 

16 play’ for each major professional league means 

17 the period of time in each calendar year begin18 ning with the date on which professional ath19 letes of that major professional league are col20 lectively obligated to report to their teams in 

21 preparation for play and ending with the last 

22 game of the major professional league’s regular 

23 season. 

24 ‘‘(B) POST-SEASON.—The season of play 

25 shall include post-season play for an athlete 
9 

•HR 2565 IH 

1 who is a member of a team that remains active 

2 in post-season play. 

3 ‘‘SEC. 724. MINIMUM UNIFORM TESTING STANDARDS. 

4 ‘‘(a) CONDUCT PROHIBITED.—It shall be unlawful 

5 for a major professional league to arrange, promote, orga6 nize, or produce a professional game without meeting the 

7 requirements in subsection (b). 

8 ‘‘(b) MINIMUM TESTING REQUIREMENTS.—Each 

9 major professional league shall implement policies and 

10 procedures for the testing of the use of prohibited sub11 stances by professional athletes who compete in each re12 spective major professional league which shall be inde13 pendently administered and shall be consistent with and 

14 as stringent as the doping control standard established by 

15 the United States Anti-Doping Agency, and which shall, 

16 at minimum, include the following: 

17 ‘‘(1) TIMING AND FREQUENCY OF TESTING.— 

18 ‘‘(A) IN GENERAL.—Each professional ath19 lete shall be tested a minimum of 5 times each 

20 calendar year that such athlete is competing in 

21 games organized by the major professional 

22 league. 

23 ‘‘(B) TIMING.—Each athlete shall be test24 ed— 
10 

•HR 2565 IH 

1 ‘‘(i) at least 3 times, each with no ad2 vance notice, during each season of play; 

3 and 

4 ‘‘(ii) at least 2 times, each with no ad5 vance notice, during the off-season. 

6 ‘‘(2) TEST DISTRIBUTION PLANNING.—Each 

7 major professional league shall certify to the Direc8 tor on or prior to December 31 of each year that it 

9 has consulted with the United States Anti-Doping 

10 Agency in the development of its test distribution 

11 plan for both season of play and off-season testing. 

12 ‘‘(3) METHOD OF TESTING.—Each major pro13 fessional league shall certify to the Director on or 

14 prior to December 31 of each year that it has con15 sulted with the United States Anti-Doping Agency in 

16 the development of its drug testing protocols for 

17 both season of play and off-season testing. 

18 ‘‘(4) APPLICABLE SUBSTANCES.—Each profes19 sional athlete shall be tested for all prohibited sub20 stances at the time of each test. A major profes21 sional league may make exceptions for any prohib22 ited substances that have been properly prescribed 

23 by a doctor of medicine licensed in the United States 

24 for legitimate and documented therapeutic purposes. 
11 

•HR 2565 IH 

1 ‘‘(5) ANALYSIS OF SAMPLE.—Each sample pro2 vided shall be analyzed by a laboratory approved by 

3 the United States Anti-Doping Agency. 

4 ‘‘(6) POSITIVE TESTS.— 

5 ‘‘(A) IN GENERAL.—A positive test shall 

6 consist of the presence in the sample of any 

7 prohibited substance or its metabolites or mark8 ers, or evidence of the use of a prohibited meth9 od, unless that substance was prescribed to the 

10 athlete in accordance with paragraph (4). 

11 ‘‘(B) REFUSAL.—A refusal by a profes12 sional athlete to submit to a test or a failure of 

13 a professional athlete to submit to a test with14 out compelling justification shall also be consid15 ered a positive test. 

16 ‘‘(7) PENALTIES.— 

17 ‘‘(A) GENERAL RULE.— 

18 ‘‘(i) FIRST VIOLATION.—Except as 

19 provided in subparagraph (B), a profes20 sional athlete who tests positive shall be 

21 immediately suspended for a minimum of 2 

22 years for a first violation. All suspensions 

23 shall include a loss of pay for the period of 

24 the suspension. 
12 

•HR 2565 IH 

1 ‘‘(ii) SECOND VIOLATION.—A second 

2 violation shall result in a lifetime ban of 

3 the professional athlete from all major pro4 fessional leagues. 

5 ‘‘(B) EXCEPTIONS.— 

6 ‘‘(i) KNOWLEDGE OF THE ATH7 LETE.—A major professional league may 

8 impose a lesser penalty than provided in 

9 subparagraph (A) or no penalty if the pro10 fessional athlete establishes that he did not 

11 know or suspect, and could not reasonably 

12 have known or suspected even with the ex13 ercise of utmost caution, that he had used 

14 the prohibited substance. 

15 ‘‘(ii) ASSISTANCE IN IDENTIFYING

16 VIOLATIONS.—A major professional league 

17 may impose a lesser penalty than provided 

18 in subparagraph (A) if the professional 

19 athlete provides substantial assistance to 

20 the major professional league in identifying 

21 violations of the league’s drug testing pol22 icy by other professional athletes or assist23 ance in violations of the league’s drug test24 ing policy by any coach, trainer, manager, 

25 agent, team staff, official, medical, or 
13 

•HR 2565 IH 

1 other personnel working with or treating 

2 professional athletes participating in or 

3 preparing for sports competition. 

4 ‘‘(8) ADJUDICATION.— 

5 ‘‘(A) CONSULTATION.—Each major profes6 sional league shall certify to the Director on or 

7 prior to December 31 of each year that it has 

8 consulted with the United States Anti-Doping 

9 Agency in the development of its adjudication 

10 process. 

11 ‘‘(B) DUE PROCESS.—If a professional 

12 athlete tests positive, the professional athlete 

13 shall have the right to notice, a fair, timely, and 

14 expedited hearing, representation by counsel 

15 and appeal. 

16 ‘‘(C) SUSPENSION.—During the pendency 

17 of any proceedings the professional athlete shall 

18 be suspended from participating in any profes19 sional game. 

20 ‘‘(9) PUBLIC DISCLOSURE.— 

21 ‘‘(A) TESTING.—A major professional 

22 league shall publicly disclose the identity of any 

23 professional player who has tested positive as 

24 well as the prohibited substance or prohibited 
14 

•HR 2565 IH 

1 method for which he tested positive not later 

2 than 30 days after receiving the test results. 

3 ‘‘(B) PENALTY.—A major professional 

4 league shall publicly disclose the name of any 

5 penalized athlete, the penalty imposed, the sub6 stance for which the player tested positive, and 

7 the reason for the penalty not later than 15 

8 days after the final disposition of the player’s 

9 case. 

10 ‘‘SEC. 725. PROMULGATION OF STANDARDS BY THE DIREC11 TOR OF THE OFFICE OF NATIONAL DRUG 

12 CONTROL POLICY. 

13 ‘‘(a) IN GENERAL.—The Director shall have the au14 thority to promulgate standards that would modify the 

15 provisions of section 724 as they apply to an individual 

16 major professional league for exceptional circumstances or 

17 for other good cause. 

18 ‘‘(b) EFFECTIVENESS MAINTAINED.—A modification 

19 under subsection (a) shall not— 

20 ‘‘(1) reduce the effectiveness of the standards in 

21 eliminating the use of steroids or other performance22 enhancing substances in any major professional 

23 league; or 
15 

•HR 2565 IH 

1 ‘‘(2) diminish the leadership role of the United 

2 States in eliminating the use of steroids or other 

3 performance-enhancing substances in sports. 

4 ‘‘(c) INCLUSION OF ADDITIONAL LEAGUES.—The Di5 rector may include an additional professional sporting 

6 league or the colleges and athletes participating in Divi7 sion I or Division II of the NCAA as a major professional 

8 league if the Director determines that such additions 

9 would prevent the use of performance-enhancing sub10 stances by high school, college, or professional athletes. 

11 ‘‘(d) DELEGATION.—The Director may delegate the 

12 administration of this subtitle to any other appropriate 

13 agency of the Federal Government. 

14 ‘‘SEC. 726. ENFORCEMENT BY THE FEDERAL TRADE COM15 MISSION. 

16 ‘‘(a) UNFAIR OR DECEPTIVE ACTS OR PRACTICES.— 

17 A violation of section 724 shall be treated as a violation 

18 of section 18 of the Federal Trade Commission Act (15 

19 U.S.C. 57a) regarding unfair or deceptive acts or prac20 tices. 

21 ‘‘(b) POWERS OF COMMISSION.— 

22 ‘‘(1) IN GENERAL.—The Commission shall issue 

23 and enforce the regulations for the enforcement of 

24 section 724 in the same manner, by the same means, 

25 and with the same jurisdiction, powers, and duties 
16 

•HR 2565 IH 

1 as though all applicable terms and provisions of the 

2 Federal Trade Commission Act (15 U.S.C. 41 et 

3 seq.) were incorporated into and made a part of this 

4 subtitle. Any person who violates such regulations 

5 shall be subject to the penalties and entitled to the 

6 privileges and immunities provided in that Act. 

7 ‘‘(2) ENHANCED PENALTY FOR VIOLATIONS.— 

8 Notwithstanding subsection (a) and the Federal 

9 Trade Commission Act, in the case of a person who 

10 violates section 724, the Commission may, in its dis11 cretion, seek a civil penalty for such violation in an 

12 amount, as determined by the Commission, of not 

13 more than $1,000,000 for each violation of section 

14 724. 

15 ‘‘(3) GENERAL AUTHORITY.—Nothing in this 

16 subtitle shall be construed to limit the authority of 

17 the Commission under any other provision of law. 

18 ‘‘SEC. 727. REPORTS TO CONGRESS. 

19 ‘‘(a) FIRST LEAGUE REPORT.— 

20 ‘‘(1) IN GENERAL.—Not later than 6 months 

21 after completion of a professional sports league’s 

22 first season of play after the effective date of this 

23 subtitle, each major professional league shall trans24 mit to the Committee on Commerce, Science, and 

25 Transportation of the Senate and the Committee on 
17 

•HR 2565 IH 

1 Energy and Commerce and the Committee on Gov2 ernment Reform of the House of Representatives, a 

3 report on its testing policies and procedures. 

4 ‘‘(2) CONTENTS.—The report required by this 

5 subsection shall contain— 

6 ‘‘(A) a comparison of the major profes7 sional league’s testing policy (including its adju8 dication procedures) to that of the United 

9 States Anti-Doping Agency, emphasizing the 

10 differences between the policies and the ration11 ales for the differences; and 

12 ‘‘(B) aggregate data on the number of pro13 fessional players tested by the major profes14 sional league and the prohibited substances de15 tected in samples or prohibited methods, includ16 ing the number of tests conducted during the 

17 season of play and during the off-season. 

18 ‘‘(b) BIENNIAL LEAGUE REPORTS.—Each major pro19 fessional league shall transmit to the Committee on Com20 merce, Science, and Transportation of the Senate and the 

21 Committee on Energy and Commerce and the Committee 

22 on Government Reform of the House of Representatives, 

23 on a biennial basis, a report containing the data and anal24 ysis required in subsection (a) for each of the 2 prior 

25 years. 
18 

•HR 2565 IH 

1 ‘‘(c) ONDCP REPORT.—Not later than 1 year after 

2 the date of enactment of this subtitle, and subsequently 

3 thereafter as determined appropriate by the Director, the 

4 Director shall report to the Committee on Commerce, 

5 Science, and Transportation of the Senate and the Com6 mittee on Energy and Commerce and the Committee on 

7 Government Reform of the House of Representatives, rec8 ommendations for improving any Federal law governing 

9 controlled substances as may be necessary for reducing the 

10 use of steroids and other performance-enhancing sub11 stances. 

12 ‘‘SEC. 728. PROMULGATION OF STANDARDS BY UNITED 

13 STATES BOXING COMMISSION. 

14 ‘‘Upon the later of 12 months after enactment of this 

15 subtitle or 12 months after the establishment of the 

16 United States Boxing Commission pursuant to Federal 

17 law, that commission shall, in consultation with the Asso18 ciation of Boxing Commissions and the United States 

19 Anti-Doping Agency, promulgate uniform performance-en20 hancing substance testing standards for professional box21 ing that are consistent with section 724. 

22 ‘‘SEC. 729. STUDY ON COLLEGE TESTING POLICIES AND 

23 PROCEDURES. 

24 ‘‘(a) STUDY.—The Government Accountability Office 

25 shall conduct a study on the use of performance-enhancing 
19 

•HR 2565 IH 

1 substances by college athletes which shall examine the pro2 hibited substance policies and testing procedures of inter3 collegiate athletic associations and college and university 

4 athletic departments. 

5 ‘‘(b) REPORT.— 

6 ‘‘(1) SUBMISSION TO CONGRESS.—Not later 

7 than 1 year after the date of enactment of this sub8 title, the Government Accountability Office shall 

9 transmit a report to the Committee on Commerce, 

10 Science, and Transportation of the Senate and the 

11 Committee on Energy and Commerce and the Com12 mittee on Government Reform of the House of Rep13 resentatives. 

14 ‘‘(2) CONTENTS.—The report required by this 

15 subsection shall— 

16 ‘‘(A) assess the adequacy of the testing 

17 policies and procedures described in subsection 

18 (a) in detecting and preventing the use of per19 formance-enhancing substances; and 

20 ‘‘(B) include recommendations to Congress 

21 regarding expanding the application of the reg22 ulations issued pursuant to this subtitle to such 

23 intercollegiate and interscholastic athletic asso24 ciations. 
20 

•HR 2565 IH 

1 ‘‘SEC. 730. COMMISSION ON HIGH SCHOOL AND COLLE2 GIATE ATHLETICS. 

3 ‘‘(a) COMMISSION.—The Director shall establish a 

4 commission on high school and collegiate athletics. 

5 ‘‘(b) REPORT.—Not later than 1 year after the date 

6 of enactment of this subtitle, the commission shall report 

7 to Congress— 

8 ‘‘(1) findings on the use of steroids and other 

9 performance-enhancing substances in high school 

10 and collegiate sports; and 

11 ‘‘(2) recommendations for reducing their use. 

12 ‘‘SEC. 731. SENSE OF CONGRESS. 

13 ‘‘It is the sense of Congress that— 

14 ‘‘(1) professional sports leagues not regulated 

15 by this subtitle should adhere to the drug testing 

16 standards established in this subtitle; 

17 ‘‘(2) all professional sports should implement 

18 policies and procedures for the testing of the use of 

19 prohibited substances or the detection of prohibited 

20 methods by professional athletes that ensure that 

21 American professional sports leagues are world lead22 ers in the effort to keep steroids and other perform23 ance-enhancing drugs out of sports; 

24 ‘‘(3) all professional sports should implement 

25 policies and procedures that address the development 

26 of designer steroids and emerging methods for 
21 

•HR 2565 IH 

1 doping, including gene doping, that enhance sports 

2 performance, are potential or actual health risks, 

3 and are contrary to the spirit of the sport; and 

4 ‘‘(4) each major professional league should 

5 produce and publicize public service announcements 

6 regarding the health and safety consequences of 

7 steroids and other similar performance-enhancing 

8 substances on children and teenagers. 

9 ‘‘SEC. 732. EFFECTIVE DATE. 

10 ‘‘This subtitle shall take effect 1 year after the date 

11 of enactment of this subtitle.’’. 

12 (b) CONFORMING AMENDMENTS.—The Office of Na13 tional Drug Control Policy Act of 1998 (Public Law 105– 

14 277; 21 U.S.C. 1701 et seq.) is further amended— 

15 (1) by striking ‘‘title’’ each place it appears and 

16 inserting ‘‘subtitle’’ in— 

17 (A) section 701; 

18 (B) section 702; 

19 (C) section 703(b)(2); 

20 (D) section 704(d)(1); and 

21 (E) the first and second sentences of sec22 tion 705(a)(2)(A); and 
22 

•HR 2565 IH 

1 (2) in section 711(b), by striking ‘‘title’’ and in2 serting ‘‘Office of National Drug Control Policy Re3 authorization Act of 1998’’. 

Æ